secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001213900-24-011360
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma acquires $2.96M Taiwan land via stock & warrants in related-party deal
--------------------------------------------------------------------------------

- Land valued at ~$2.96M; consideration is 703,495 restricted shares at $3.50/share plus 5-yr warrants for 1M shares at $2.00.
- Seller Shuling Jiang is a director, holds ~10% of ABVC stock, and is married to the Chief Strategic Officer.
- Land to be used for GAP plant factories for botanical drug raw materials; closing targeted by March 10, 2024.
- Stock issuance exempt under Section 4(a)(2) and Regulation S; no registration for the unregistered shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024011360/0001213900-24-011360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024011360/ea193134-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-011360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer